Gelofusine'

Modified Fluid GelatinlUfq 4o/o 30.a00 dt.

Not all gelatins are the same

Etl
tf
e
\d,
N
a

t\\

tt

of Colloid Gelatin

a Xm mce

\. **{

lu nre
\5, hera
Gelofusine'

Comparable to HES 130 and Alhumin

Special raolecular structure and negative charge of

Gelofusine@ repelled to capillary endothelium and
results in Prolonged retention in circulation
C'l (r'2)
/i
//'-
/
tq

Colloid Osmotic Pressure (COP)

Gelofusine@ comparable to Albumin

and superior than other Gelatin for
effective treatrnent of hypovolemia (2)

Urta-linktd Hunan Gelofiainco

Grlatin Alhumin

C0PsolCOP* ratios (as indicator fsr plasma rctefltion). Adapted ftomr.

[mt]rOO
---..ea &-iofusincm (O) 4c*]

-\ Over the 6 hours infusion, the volume

and duration effect of Gelofusineo
200 (so kdl) similar compare to HES
100, (tso kdt) or

rcffiffiryil{#*
0123{56
Tine [hourl
Changts in blod volurrc and extravascular fluid tolume after lnfilsion of
t litrc of 0.9tlb sline (5), 4qt modified fluid gelatin {6) and 6oh HES 130 M
ovrr t hourr.
p values S vs G < 0.0@l ; Svs V< 0.0@l; 6 vsV= 0.70
 Gelofusine'

No Risk Hypercloremic Acidosis

0elafusine* contain plasma-like chloride (120 mmoUL),

Based on Stewart approach, Gelofirsine'Nri Risk Hypercloremic Acidosis compare

(+.s)
HES based NaCl

Table 6. Six colloid solutions

Albumex 4 l-larmamrl Gelofusinco PTNTASPAN HESpan Hextend

[Albuminlb 40dr
{Gelatin urea-linkrdlb 3s s/l
l6datin sueeinylated]b ao s,l

IPentastarchl 100 9/l

[Hetastarch] 60 sll 60 g,l

lNa-J 140 r49 154 154 154 143

IK'] 5.1 3

lca*1 r 2.5 5

[ilrt9r-1 o.8

terl 1?8 145 120 154 154 124

[L-lactate] 28

[Glucose] 5-5

fOctanoattl 6.4

Effettive SlD 12 17.6 34 26r

3Assumes stab'le plasma lactate

concentrations of 2 mmsUl (see text). Week acid. Electrolyte concentrations are give in mEqfl. SlD,
strong in difference

PTASMA + HEVNaO PTASMA + Gelofusine 0tla* t54 nrmoUL Cl- 120 mnrol&)

:B:
SID: 39 + 19 = risk hyperclorernic acidosis SID: 39 + 37 = No hypercloremic acidosis
compare other NaCl base
 Safety Profile

hckrc of onqpilffi fnr dr'ftrcfi r corbid

,rckhrt
h$
Minimol anaphylwcis
unJ B lG{
a.&e
tlrta
tdir.ar
sl{*
ret
r$ol
F&6

e.l
Minimol anaphyloxis of
o, Gelofusine' com pa ra ble
with HES Et Albumin. (d
ct

Aemla* Oltrp tS EcMr !.h*r

F- ae56a 634s6-l

6 Minimal
ll-
Q coagulation effrcf
C'

Gelafusine' minimal
coagulation effect
compare to HES. {7)
{&b Dihtim
D 6EL0FrJstr{F Et }tEs r30 Hs 200
Br @r GELCIRtSttE }tEs 130 I GElt REt}tpIHES zm

(ctr)
5{}.

50. Minimal rcnaleffecf

4t!.
,0,1 0elofusine'minimal risk ARF in patients
l

20,'t with severe sepsis or septic shock compare

,r.l 1o g69 ta)
..]
ARF oliguria
JGelofusineo ffi6fr l{ES 2mlo.62
E-,

Gelofusine';u

Worldwide tried and Tested

Fluid Loss
(Maintenance)
ICU Peri 0perative

I T
Tetraspa
J
n'f Venofu nd n'
Ringerfundin* Gelofusine' i

J
lf patients ore of risk far rensl
failure / coogulatian disarder

T
Gelofusine*

Gelofusiheo - product characteristics

Active ingredient Modified fluid qelatin

Concentration 40 [4q)]

Electrolytes : Sodiunr (mrnol/l) 154

ehloride (rnmoUl) 124

7,4 r'0.3

Theoritical osmol a rity 274

(m0sm/l)

Volume effeet 100%

Cli nically relevant d umtion 4 hours

of volume expansion
 Product Sqq.ification

Gcloturlnc!
&rlrldor Ilpnlcutlc ldhrtau sgcli.l xrtrf!3 rJ prtcrrtiorr for rrr
flm d rdrdon a!.ltala: Colloldrl plrmr rulum! lubstit tc h. ocldUrioc! lhould b..dnlnlsH with aution Aft er the sd iiiiaist'5lion otGrLlfiialntt infi5iort{
b p.ticoB dth . hlstory of rllcrgic dis.rs.s, .{. just a3.deni crdloldel'voluar.srs<thunt anr
Suctinylrhd glbtln - PmgMrb.rd t r.t ncnt ot rtliliw rsOrrn plrybetob rmctbrs of WyinS dlSru5 ol sarcrity
(- nodiftd f,uid grlrtinl ,10I)0 9 o, &oqrE hygsrlbcnb rd of drosh maY ocelr
- P4hyB of hypotr0do, {co.r,utiq iduction &lofirfipsbuld mly bc dminisEtrrt nith
lffohcub'$dght
It,ghl.r,rrE[x 3Om 0iloo
of oEurl or Cnrl enccsilril; crutbn s Tlr.ftqiidinigof undrsid!& fisctr of
- ?ntdu[ls invDlyi0q Crtra6iD0|tal ci'tublbn &lofurl.i*:rs,,! folla$r
,lrolarlb?nEnl lc{. hcrt.lung rrdline); - ddrdy pDtiolB Lr!: rnrlMtcbid cl(tian all tnd6
nurnbcraoae Armlhhon) - Agltc nonnoolicmh hrcatodiludon. - Fti.nB .t iirt duc to dltrr|.tory orlrlcd t{. liry r,c:Saert arphrlactoid mctio{6
FticnB f,ith coogtrtilt hcrn hiErt. right thcr.5rr: Inmitnt mild nel'aa or abdominal
Sodium rhloridc 70t 0 Catrhdlrrdor ortrt rt. Uiclrb? intullhicncL lrypcrtailion, paiclramicnt milil t*e of lodylqmrrat.uit .,
EdduCrlc. ilrtrt not be.dminiftGd iil cr* of: Fdmoftrry oldafiL or ,tnal inruffic'rcrq wittr
EGcroit olhe or mudr. t &a!|!l irrkrntcn l8
Sdium t5l nrrltul - ]ryI!|rsritiuiv to rnyotthr aomtitrlnts d lilll2 MrkunEnm Qemrnf
Chlor5. t2omtlb0 llndulhO h srch dtr! Gclofurin:r rhould ody tc giYtn
Ihco,ldt.lGmd$it : Z7a m0sn0
- irnrmbcmb, mdn (rcful monitqiae d tllG prthrf3
7.4r03
- hyD!.t?doflon. h-rodyrBmlc n'turtioL
9ll: - lrtrc ordhr ltEufici('rcr.
- **'G blo.d colgulrtio[ d!odc6.

Reference:

1. WilkesN)etal.,,AnesthAnalgg3(2Nl)Theeffectsofboloncedversussoline-bosedhetostorchandcrystalloidsolutionsonocid-bqseondelectrolytestotus
and gostric mucosal peffusion in elderly surgical patients

2. Webb A R et ol. lntensive Cdre Med 15 {1989) ln vitro calloid osmatic pressure of commonly used plasmo exponde rs (Aebfusine) ond substitutes: a study of the
di ffit sibil ity of col I o id molecu les

3. Lobo DN:, Crit Care Med" 2010, Effect af volume looding with 1 liter intravenous infusions of o"99b soline, 4% Gelofusine and 6ch HES (Voluven) on blood volume
and endocrine responses.' o rondamized, three-woy crossover study in heolthy volunteers.

4. Y WH George slide The effect of Fluid lheropy on ocid base balonced (Stewort oppraach) t penonal communicotion

5. TJ Margon, Critical Core April 2AOS The meoning of acid-bosc obnormolities in the ICU - effects of fluid sdministrotion
6. Laxenoire,M-'C.etol.AnnFrAesthReonimlS(1gg4)301-31Oand Lundsgoord-HonsenP.etot.DevBiolStond4S(1980)251-256

7. Fries D. et ol. Anesth Anotg 20a2, The Effect of the Combined Administrotion of Colloids (1etotusine t HES) on the Coogulotion System: An tn Wtro Study lJsing
Thrombela siagroph Coog u latian Analysis

8. Schartgen, F. et ol.: ly'.NCET, 2N? Mor 24 Effects of Hydroryethylstorch ond Gelotin an renol functian in severe sepsis: a multicenter rondarnised study

BIBRAUN
SHARlNG EXPERTISE
P[. B, Braun Mcdical lndonesia
PalmaOne Building, 14s Floor
ll.
H.R. Rasuna Said Kav. X-2 No.4
Jakarta 1 2950, lndonesia
Tel : (oz zt) 529a7177 (Hunting)
Fax : (oz 2r) 5290 7178
customer Service :162 ?1) 529A n7O
e-mail : ptbmi.info@ bbraun.conr
www.bbraun.eom